Parminder Sobti

Parminder Sobti is a seasoned finance professional with extensive experience in various leadership roles within the pharmaceutical and financial sectors. Currently serving as the Senior Finance Director for FP&A (EMEA) at ICU Medical since February 2017, Parminder has been instrumental in establishing a dedicated FP&A organization with a regional revenue responsibility of approximately $400 million. Previous positions include Finance Director at Pfizer, where the role transitioned post-acquisition of Hospira Infusion Systems, and Project Director as an Independent Pharma Consultant managing market evaluation for a U.S.-based oncology organization. Parminder's earlier experience includes leadership positions at Aurobindo Pharma Ltd, managing commercial operations across several European countries, and setting up European finance teams. Notable contributions also include work at Ernst & Young and KPMG, focusing on transaction support and audit services, respectively. Parminder holds an FCA qualification from ICAEW, an ACA accreditation, and a Bachelor of Commerce from Panjab University.